Euglycemic Time-Action Profile Glucose Clamps

About

The most reliable method for quantifying the pharmacodynamic properties of a new insulin preparation (onset of action; peak action; end of glucose-lowering action) is the euglycemic glucose clamp technique. Glucose is infused intravenously at a variable rate to maintain blood glucose at euglycemia following the administration of the test insulin preparation. Most often this will be a subcutaneous injection but the technique is adaptable for insulin delivered by other routes, e.g. pulmonary insulin, oral insulin. Clamp-derived time-action profiles are mandated by US and European regulators for market approval of new insulins and biosimilar insulins.

Euglycemic Time-Action Profile Glucose Clamps thumbnail

Recommended Materials

Euglycemic Time-Action Profile Glucose Clamps thumbnail

Articles

Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects.

Euglycemic Time-Action Profile Glucose Clamps thumbnail

Articles

Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2

Euglycemic Time-Action Profile Glucose Clamps thumbnail

Fact Sheets

Hypoglycemic Clamp Studies

Related Solutions

Automated Glucose Clamp Techniques thumbnail

Specialized Methods

Steatotic Liver Disease thumbnail

Experts in steatotic liver disease clinical research